Work

Putative biomarkers of response to anti-PD-1 therapy in metastatic castration-resistant prostate cancer (mCRPC).

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.6_suppl.155

Authors: Khobe Chandran, Maria Dolores Fenor de la Maza, Jan Rekowski, Irene Shui, Bora Gurel, Pasquale Rescigno, Emily Cross, Suzanne Carreira, Wei Yuan, Ines Figueiredo, Ana Ferreira, Mateus Crespo, Susana Miranda, Claudia Bertan, Veronica Gil, Ruth Riisnaes, Razvan Cristescu, Charles Schloss, Christina Yap, Johann S. De Bono

Institutions: Institute of Cancer Research, Merck & Co., Inc., Rahway, NJ, USA (United States), Royal Marsden NHS Foundation Trust, Royal Marsden Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3134377177

Cites:

Cited by:

Related to: 10